Abstract ISI
JOURNAL OF CLINICAL ONCOLOGY  (2019)

Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059.

Catenacci, DVT; Ku, GY; Bleeker, JS; Bang, YJ; Chung, HC; Hazzard, A

Más información

Título según WOS: Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059.
Título de la Revista: JOURNAL OF CLINICAL ONCOLOGY
Volumen: 37
Número: 15
Editorial: LIPPINCOTT WILLIAMS & WILKINS
Fecha de publicación: 2019
Idioma: English
DOI:

10.1200/JCO.2019.37.15_suppl.4009
Notas: ISI